Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Cyclohexapentylose, also known as α-Cyclodextrin, is a naturally occurring clathrate compound that forms hexagonal plates or blade-shaped needles. It is a white crystalline powder with a slightly sweet taste and is derived from starch through the action of cyclodextrin glucanotransferase. Cyclohexapentylose has the unique ability to form inclusion complexes with various guest molecules, making it a versatile compound with applications in various industries.

10016-20-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 10016-20-3 Structure
  • Basic information

    1. Product Name: Alfadex
    2. Synonyms: SCHARDINGER ALPHA-DEXTRIN;CYCLOHEXAAMYLOSE;CYCLOMALTOHEXAOSE;CYCLOMALTOHEXOSE;ALPHA-CYCLODEXTRIN;2,4,7,9,12,14,17,19,22,24,27,29-Dodecaoxaheptacyclo(26.2.2.23,6.28,11.213,16.218,21.223,26)dotetracontane-31,32,33,34,35,36,37,38,39,40,41,42-dodecol, 5,10,15,20,25,30-hexakis(hydroxymethyl)-;Alfadex;alpha-Cycloamylose
    3. CAS NO:10016-20-3
    4. Molecular Formula: C36H60O30
    5. Molecular Weight: 972.84
    6. EINECS: 233-007-4
    7. Product Categories: Industrial/Fine Chemicals;Biochemistry;Cyclodextrins;Functional Materials;Macrocycles for Host-Guest Chemistry;Oligosaccharides;Sugars;Dextrins、Sugar & Carbohydrates
    8. Mol File: 10016-20-3.mol
    9. Article Data: 38
  • Chemical Properties

    1. Melting Point: >278 °C (dec.)(lit.)
    2. Boiling Point: 784.04°C (rough estimate)
    3. Flash Point: 807.1 °C
    4. Appearance: White/powder
    5. Density: 1.2580 (rough estimate)
    6. Vapor Pressure: 0mmHg at 25°C
    7. Refractive Index: 1.7500 (estimate)
    8. Storage Temp.: Store at RT.
    9. Solubility: H2O: 50 mg/mL
    10. PKA: 11.77±0.70(Predicted)
    11. Water Solubility: Soluble in water at 1%(w/v)
    12. Stability: Stable. Combustible. Incompatible with strong oxidizing agents.
    13. Merck: 14,2718
    14. BRN: 4227442
    15. CAS DataBase Reference: Alfadex(CAS DataBase Reference)
    16. NIST Chemistry Reference: Alfadex(10016-20-3)
    17. EPA Substance Registry System: Alfadex(10016-20-3)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36-36/37/38
    3. Safety Statements: 26-36
    4. WGK Germany: 3
    5. RTECS: GU2292000
    6. TSCA: Yes
    7. HazardClass: N/A
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 10016-20-3(Hazardous Substances Data)

10016-20-3 Usage

Uses

Used in Pharmaceutical Applications:
Cyclohexapentylose is used as a pharmaceutical ingredient for its ability to enhance the solubility, stability, and bioavailability of drugs. It is also used to lower blood low-density lipoprotein cholesterol levels and lower blood triglyceride levels.
Used in Food and Beverage Applications:
Cyclohexapentylose is used as a fiber ingredient, an odor or flavor masking agent, and for emulsification applications. It is also used as a whipping fiber and emulsifying fiber, playing an essential role in fat-free or fat-containing dessert compositions. Additionally, it is employed for the reduction or replacement of egg white in confectionary and bakery applications.
Used in Medical and Healthcare Applications:
Cyclohexapentylose is used to increase the insulin and leptin sensitivity, making it a valuable compound in the medical and healthcare industries.
Used as a Supramolecular Carrier, Complexing Agent, and Controlled Drug Release:
Cyclohexapentylose is used as a supramolecular carrier, complexing agent, and for controlled drug release due to its ability to form inclusion complexes with various guest molecules.

Production Methods

Cyclodextrins are manufactured by the enzymatic degradation of starch using specialized bacteria. For example, β-cyclodextrin is produced by the action of the enzyme cyclodextrin glucosyltransferase upon starch or a starch hydrolysate. An organic solvent is used to direct the reaction that produces β-cyclodextrin, and to prevent the growth of microorganisms during the enzymatic reaction. The insoluble complex of β-cyclodextrin and organic solvent is separated from the noncyclic starch, and the organic solvent is removed in vacuo so that less than 1 ppm of solvent remains in the β-cyclodextrin. The β-cyclodextrin is then carbon treated and crystallized from water, dried, and collected.

Reactivity Profile

Cyclohexapentylose has hydrophobic cavities. Cyclohexapentylose forms inclusion compounds with organic substances, salts, and halogens in the solid state or in aqueous solutions. Cyclohexapentylose is incompatible with strong oxidizing agents.

Fire Hazard

Flash point data for Cyclohexapentylose are not available; however, Cyclohexapentylose is probably combustible.

Flammability and Explosibility

Nonflammable

Pharmaceutical Applications

Cyclodextrins are ‘bucketlike’ or ‘conelike’ toroid molecules, with a rigid structure and a central cavity, the size of which varies according to the cyclodextrin type. The internal surface of the cavity is hydrophobic and the outside of the torus is hydrophilic; this is due to the arrangement of hydroxyl groups within the molecule. This arrangement permits the cyclodextrin to accommodate a guest molecule within the cavity, forming an inclusion complex.Cyclodextrins may be used to form inclusion complexes with a variety of drug molecules, resulting primarily in improvements to dissolution and bioavailability owing to enhanced solubility and improved chemical and physical stability.Cyclodextrin inclusion complexes have also been used to mask the unpleasant taste of active materials and to convert a liquid substance into a solid material. a-Cyclodextrin is used mainly in parenteral formulations. However, as it has the smallest cavity of the cyclodextrins it can form inclusion complexes with only relatively few, small-sized molecules. In contrast, g-cyclodextrin has the largest cavity and can be used to form inclusion complexes with large molecules; it has low toxicity and enhanced water solubility. In parenteral formulations, cyclodextrins have been used to produce stable and soluble preparations of drugs that would otherwise have been formulated using a nonaqueous solvent. In eye drop formulations, cyclodextrins form water-soluble complexes with lipophilic drugs such as corticosteroids. They have been shown to increase the water solubility of the drug; to enhance drug absorption into the eye; to improve aqueous stability; and to reduce local irritation.Cyclodextrins have also been used in the formulation of solutions,suppositories, and cosmetics.

Biochem/physiol Actions

α-Cyclodextrin is found to form a firm complex with dietary fats. This way it decreases the bioavailability and absorption of fats. It is known to regulate triglyceride and leptin levels in serum. In rat models, α-Cyclodextrin is shown to induce insulin sensitivity and fecal fat excretion. Thus, α-cyclodextrin is considered to be effective for treating obesity and metabolic syndromes.

Safety

Cyclodextrins are starch derivatives and are mainly used in oral and parenteral pharmaceutical formulations. They are also used in topical and ophthalmic formulations. Cyclodextrins are also used in cosmetics and food products, and are generally regarded as essentially nontoxic and nonirritant materials. However, when administered parenterally, β-cyclodextrin is not metabolized but accumulates in the kidneys as insoluble cholesterol complexes, resulting in severe nephrotoxicity. Cyclodextrin administered orally is metabolized by microflora in the colon, forming the metabolites maltodextrin, maltose, and glucose; these are themselves further metabolized before being finally excreted as carbon dioxide and water. Although a study published in 1957 suggested that orally administered cyclodextrins were highly toxic, more recent animal toxicity studies in rats and dogs have shown this not to be the case, and cyclodextrins are now approved for use in food products and orally administered pharmaceuticals in a number of countries. Cyclodextrins are not irritant to the skin and eyes, or upon inhalation. There is also no evidence to suggest that cyclodextrins are mutagenic or teratogenic. α-Cyclodextrin LD50 (rat, IP): 1.0 g/kg(15) LD50 (rat, IV): 0.79 g/kg

storage

Cyclodextrins should be stored in a tightly sealed container, in a cool, dry place.Cyclodextrins are stable in the solid state if protected from high humidity.

Purification Methods

Recrystallise α-cyclodextrin from 60% aqueous EtOH, then twice from water, and dry it for 12hours in a vacuum at 80o. It is also purified by precipitation from water with 1,1,2-trichloroethylene. The precipitate is collected, washed and resuspended in water. This is boiled to steam distil the trichloroethylene. The solution is then freeze-dried to recover the cyclodextrin. [Armstrong et al. J Am Chem Soc 108 1418 1986]. [Beilstein 19/12 V 789.]

Regulatory Status

Included in the FDA Inactive Ingredients Database: α-cyclodextrin (injection preparations); β-cyclodextrin (oral tablets, topical gels); γ-cyclodextrin (IV injections). Included in the Canadian List of Acceptable Non-medicinal Ingredients (stabilizing agent; solubilizing agent ); and in oral and rectal pharmaceutical formulations licensed in Europe, Japan, and the USA.

Check Digit Verification of cas no

The CAS Registry Mumber 10016-20-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,0,1 and 6 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 10016-20:
(7*1)+(6*0)+(5*0)+(4*1)+(3*6)+(2*2)+(1*0)=33
33 % 10 = 3
So 10016-20-3 is a valid CAS Registry Number.
InChI:InChI=1/C36H60O30/c37-1-7-25-13(43)19(49)31(55-7)62-26-8(2-38)57-33(21(51)15(26)45)64-28-10(4-40)59-35(23(53)17(28)47)66-30-12(6-42)60-36(24(54)18(30)48)65-29-11(5-41)58-34(22(52)16(29)46)63-27-9(3-39)56-32(61-25)20(50)14(27)44/h7-54H,1-6H2/t7-,8-,9-,10-,11-,12-,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23-,24-,25-,26-,27-,28-,29-,30-,31-,32-,33-,34-,35-,36-/m1/s1

10016-20-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (C0776)  α-Cyclodextrin  >98.0%(HPLC)

  • 10016-20-3

  • 10g

  • 590.00CNY

  • Detail
  • TCI America

  • (C0776)  α-Cyclodextrin  >98.0%(HPLC)

  • 10016-20-3

  • 25g

  • 990.00CNY

  • Detail
  • TCI America

  • (C0776)  α-Cyclodextrin  >98.0%(HPLC)

  • 10016-20-3

  • 100g

  • 2,450.00CNY

  • Detail
  • Sigma-Aldrich

  • (A1225000)  Alfadex  European Pharmacopoeia (EP) Reference Standard

  • 10016-20-3

  • A1225000

  • 1,880.19CNY

  • Detail
  • USP

  • (1154558)  AlphaCyclodextrin  United States Pharmacopeia (USP) Reference Standard

  • 10016-20-3

  • 1154558-500MG

  • 4,662.45CNY

  • Detail

10016-20-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name α-cyclodextrin

1.2 Other means of identification

Product number -
Other names CYCLOHEXAAMYLOSE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:10016-20-3 SDS

10016-20-3Synthetic route

2I,3I,2II,3II,2III,3III,2IV,3IV,2V,3V,2VI,3VI-dodeca-O-benzyl-maltocyclohexaose

2I,3I,2II,3II,2III,3III,2IV,3IV,2V,3V,2VI,3VI-dodeca-O-benzyl-maltocyclohexaose

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
With hydrogen; palladium dihydroxide In methanol; water at 20℃; for 12h;100%
1-deoxy-1-fluoro-α-D-glucose
2106-10-7

1-deoxy-1-fluoro-α-D-glucose

A

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

B

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
With sodium hydroxide; cyclodextrin-α(1-4)glucosyltransferase In water at 45℃; for 0.333333h; pH=6.0, sodium acetate buffer;A 38%
B 30%
α-cyclodextrin-Methyl Orange complex
64887-49-6

α-cyclodextrin-Methyl Orange complex

A

methyl orange
547-58-0

methyl orange

B

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
In water at 25℃; Equilibrium constant;
In methanol; water at 25℃; Equilibrium constant;
In water; dimethyl sulfoxide at 25℃; Equilibrium constant;
C36H60O30*C9H7NO6

C36H60O30*C9H7NO6

A

4-(acetyloxy)-3-nitrobenzoic acid
1210-97-5

4-(acetyloxy)-3-nitrobenzoic acid

B

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
With phosphate buffer at 25℃; Equilibrium constant;
C36H60O30*C11H11NO6

C36H60O30*C11H11NO6

A

4-carboxy-2-nitrophenyl butanoate
56003-42-0

4-carboxy-2-nitrophenyl butanoate

B

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
With phosphate buffer at 25℃; Equilibrium constant;
2C36H60O30*C11H11NO6

2C36H60O30*C11H11NO6

A

C36H60O30*C11H11NO6

C36H60O30*C11H11NO6

B

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
With phosphate buffer at 25℃; Equilibrium constant;
2C36H60O30*C13H15NO6

2C36H60O30*C13H15NO6

A

C36H60O30*C13H15NO6

C36H60O30*C13H15NO6

B

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
With phosphate buffer at 25℃; Equilibrium constant;
C36H60O30*C13H15NO6

C36H60O30*C13H15NO6

A

3-nitro-4-hexanoyloxybenzoic acid
65293-27-8

3-nitro-4-hexanoyloxybenzoic acid

B

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
With phosphate buffer at 25℃; Equilibrium constant;
C36H60O30*C14H17NO6

C36H60O30*C14H17NO6

A

4-carboxy-2-nitrophenyl heptanoate
43049-38-3

4-carboxy-2-nitrophenyl heptanoate

B

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
With phosphate buffer at 25℃; Equilibrium constant;
2C36H60O30*C14H17NO6

2C36H60O30*C14H17NO6

A

C36H60O30*C14H17NO6

C36H60O30*C14H17NO6

B

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
With phosphate buffer at 25℃; Equilibrium constant;
2C36H60O30*C15H19NO6

2C36H60O30*C15H19NO6

A

C36H60O30*C15H19NO6

C36H60O30*C15H19NO6

B

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
With phosphate buffer at 25℃; Equilibrium constant;
C36H60O30*C15H19NO6

C36H60O30*C15H19NO6

A

3-nitro-4-(octanoyloxy)benzoic acid
113894-26-1

3-nitro-4-(octanoyloxy)benzoic acid

B

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
With phosphate buffer at 25℃; Equilibrium constant;
C37H47N3(2+)*C36H60O30*2Br(1-)
141484-63-1

C37H47N3(2+)*C36H60O30*2Br(1-)

A

C37H47N3(2+)*2Br(1-)
141484-62-0

C37H47N3(2+)*2Br(1-)

B

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
In water-d2 at 30℃; Equilibrium constant; other temperatures;
C36H60O30*C6H13N3OS

C36H60O30*C6H13N3OS

A

3-t-butyl-1-methyl-1-nitrosothiourea
95598-14-4

3-t-butyl-1-methyl-1-nitrosothiourea

B

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
With acetate buffer at 37℃; Rate constant; dissociation constant and catalyzed rate constant of the inclusion complex is determined;
C36H60O30*C12H14N2
114987-35-8

C36H60O30*C12H14N2

A

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

B

1,1'-dimethyl-1,1'-dihydro-4,4'-bipyridyl
25128-26-1

1,1'-dimethyl-1,1'-dihydro-4,4'-bipyridyl

Conditions
ConditionsYield
In water at 25℃; Equilibrium constant;
C36H60O30*C14H11N2O3(1-)
85090-50-2

C36H60O30*C14H11N2O3(1-)

A

4-(4-Hydroxy-2-methyl-phenylazo)-benzoic acid anion
85090-40-0

4-(4-Hydroxy-2-methyl-phenylazo)-benzoic acid anion

B

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
In water at 19 - 25℃; Equilibrium constant; pH = 7.2; phosphate buffer; ionic strength of 0.15M,;
prostacyclin*α-cyclodextrin
77192-49-5

prostacyclin*α-cyclodextrin

A

7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-((E)-(S)-3-hydroxy-oct-1-enyl)-cyclopentyl]-6-oxo-heptanoic acid
58962-34-8

7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-((E)-(S)-3-hydroxy-oct-1-enyl)-cyclopentyl]-6-oxo-heptanoic acid

B

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
With phosphate buffer (pH=ca. 7); water at 10 - 30℃; Thermodynamic data; Kinetics; activation parameters: ΔS(excit.), ΔG(excit.), E investigated;
C36H60O30*C21H34O5
69377-71-5

C36H60O30*C21H34O5

A

6-keto-PGF1α methyl ester
63557-55-1

6-keto-PGF1α methyl ester

B

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
With phosphate buffer (pH=ca. 7); water at 10 - 30℃; Thermodynamic data; Kinetics; activation parameters: ΔS(excit.), ΔG(excit.), E investigated;
hexakis-(2,3,6-tri-O-benzyl)-α-cyclodextrin
110237-97-3, 123930-57-4, 150520-16-4

hexakis-(2,3,6-tri-O-benzyl)-α-cyclodextrin

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In methanol; formic acid at 50℃; Yield given;
allyl O-(2,3,4-tri-O-benzyl-α-D-glucopyranosyl)-(1<*>4)-2,3,6-tri-O-benzyl-β-D-glucopyranoside
113879-86-0

allyl O-(2,3,4-tri-O-benzyl-α-D-glucopyranosyl)-(1<*>4)-2,3,6-tri-O-benzyl-β-D-glucopyranoside

allyl O-(4-O-acetyl-2,3,6-tri-O-benzyl-α-D-glucopyranosyl)-(1->4)-bis
113842-96-9

allyl O-(4-O-acetyl-2,3,6-tri-O-benzyl-α-D-glucopyranosyl)-(1->4)-bis

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
Yield given. Multistep reaction;
O-(4-O-acetyl-2,3,6-tri-O-benzyl-α-D-glucopyranosyl)-(1->4)-2,3,6-tri-O-benzyl-β-D-glucopyranosyl fluoride
113842-86-7

O-(4-O-acetyl-2,3,6-tri-O-benzyl-α-D-glucopyranosyl)-(1->4)-2,3,6-tri-O-benzyl-β-D-glucopyranosyl fluoride

O-(2,3,6-tri-O-benzyl-α-D-glucopyranosyl)-(1->4)-bis
113842-97-0

O-(2,3,6-tri-O-benzyl-α-D-glucopyranosyl)-(1->4)-bis

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
Yield given. Multistep reaction;
C36H60O30*C20H15O2(1-)*Na(1+)

C36H60O30*C20H15O2(1-)*Na(1+)

A

sodium 4-pyren-1-ylbutyrate
63442-80-8

sodium 4-pyren-1-ylbutyrate

B

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
In water at 25℃; Equilibrium constant;
2C36H60O30*C20H15O2(1-)*Na(1+)

2C36H60O30*C20H15O2(1-)*Na(1+)

A

C36H60O30*C20H15O2(1-)*Na(1+)

C36H60O30*C20H15O2(1-)*Na(1+)

B

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
In water at 25℃; Equilibrium constant;
C36H60O30*ClO4(1-)

C36H60O30*ClO4(1-)

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
In water at 25℃; Equilibrium constant;
benzophenone-α-cyclodextrin

benzophenone-α-cyclodextrin

A

benzophenone
119-61-9

benzophenone

B

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
In water at 19.9℃; Equilibrium constant;
C36H60O30*I(1-)

C36H60O30*I(1-)

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
In water at 25℃; Equilibrium constant;
C36H60O30*CNS(1-)

C36H60O30*CNS(1-)

A

potassium thioacyanate
333-20-0

potassium thioacyanate

B

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
In water at 25℃; Equilibrium constant; Thermodynamic data; partial molal volume change, atmospheric pressure;
C36H60O30*C11H15NO2

C36H60O30*C11H15NO2

A

ethyl p-dimethyaminolbenzoate
10287-53-3

ethyl p-dimethyaminolbenzoate

B

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
In water Equilibrium constant;
C36H60O30*C16H11N2O4S(1-)

C36H60O30*C16H11N2O4S(1-)

A

5-(4-hydroxyphenylazo)naphthalene-1-sulphonate
98928-28-0

5-(4-hydroxyphenylazo)naphthalene-1-sulphonate

B

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
In water at 25℃; Equilibrium constant; phosphate buffer pH 4.6;
C36H60O30*C16H10N2O4S(2-)

C36H60O30*C16H10N2O4S(2-)

A

C16H10N2O4S(2-)
99477-41-5

C16H10N2O4S(2-)

B

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Conditions
ConditionsYield
In water at 25℃; Equilibrium constant; phosphate buffer pH 11.8;
alpha cyclodextrin
10016-20-3

alpha cyclodextrin

hexakis-(6-deoxy-6-iodo)-α-cyclodextrin
131105-41-4

hexakis-(6-deoxy-6-iodo)-α-cyclodextrin

Conditions
ConditionsYield
With iodine; triphenylphosphine In N,N-dimethyl-formamide at 70℃; for 20h; Inert atmosphere;100%
With tetraethylammonium iodide; 4-pyrrolidin-1-ylpyridine; ethanaminium,N-(difluoro-λ4-sulfanylidene)-N-ethyl-,tetrafluoroborate In N,N-dimethyl-formamide at 20℃; regioselective reaction;91%
With Iod; triphenylphosphine In N,N-dimethyl-formamide at 80℃; for 15h;80%
acetic anhydride
108-24-7

acetic anhydride

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

hexakis(2,3,6-tri-O-acetyl)-α-cyclomaltohexaose
23661-37-2

hexakis(2,3,6-tri-O-acetyl)-α-cyclomaltohexaose

Conditions
ConditionsYield
In pyridine100%
With iodine at 20℃; for 24h; neat (no solvent);100%
With pyridine at 60℃; for 12h;100%
1,12-Diaminododecane
2783-17-7

1,12-Diaminododecane

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

2C36H60O30*C12H28N2

2C36H60O30*C12H28N2

Conditions
ConditionsYield
In water for 13h; Reflux;100%
In water at 20℃; Reflux;
In water at 20℃; Reflux;
benzyl chloride
100-44-7

benzyl chloride

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

hexakis-(2,3,6-tri-O-benzyl)-α-cyclodextrin
110237-97-3, 123930-57-4, 150520-16-4

hexakis-(2,3,6-tri-O-benzyl)-α-cyclodextrin

Conditions
ConditionsYield
With sodium hydride In dimethyl sulfoxide at 20℃; for 22h; Inert atmosphere; Schlenk technique;99%
In dimethyl sulfoxide at 20℃; Inert atmosphere;98%
With sodium hydride In dimethyl sulfoxide at 20℃; for 18h;95%
propionic acid anhydride
123-62-6

propionic acid anhydride

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

per-O-propionyl-α-cyclodextrin

per-O-propionyl-α-cyclodextrin

Conditions
ConditionsYield
With iodine at 80℃; for 24h; neat (no solvent);99%
propionic acid anhydride
123-62-6

propionic acid anhydride

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

propionyl-α-cyclodextrin

propionyl-α-cyclodextrin

Conditions
ConditionsYield
With pyridine at 80℃; for 12h;98%
With pyridine for 24h; Ambient temperature;
poly(ethylene glycol)-carboxylic acid, carboxyl content 6.88E-5 mol/g, Mw = 33300, PDI = 1.1

poly(ethylene glycol)-carboxylic acid, carboxyl content 6.88E-5 mol/g, Mw = 33300, PDI = 1.1

1-Adamantanamine
768-94-5

1-Adamantanamine

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

poly(ethylene glycol) 3500, bis[N-(1-adamantyl)aminocarbonyl]-terminated, inclusion complex with α-cyclodextrin, Mw = 118000, PDI = 1.2

poly(ethylene glycol) 3500, bis[N-(1-adamantyl)aminocarbonyl]-terminated, inclusion complex with α-cyclodextrin, Mw = 118000, PDI = 1.2

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 4℃;98%
butanoic acid anhydride
106-31-0

butanoic acid anhydride

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

per-O-butyryl-α-cyclodextrin
1258780-44-7

per-O-butyryl-α-cyclodextrin

Conditions
ConditionsYield
With iodine at 80℃; for 24h; neat (no solvent);98%
With pyridine at 80℃; for 12h;98%
acetic anhydride
108-24-7

acetic anhydride

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

C72H96O48

C72H96O48

Conditions
ConditionsYield
With methanesulfonic acid In neat (no solvent) at 30 - 35℃; for 0.166667h; Green chemistry;98%
2-Methylpropionic anhydride
97-72-3

2-Methylpropionic anhydride

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

C108H168O48

C108H168O48

Conditions
ConditionsYield
With pyridine at 80℃; for 12h;98%
Octanethiol
111-88-6

Octanethiol

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

C8H18S*C36H60O30
1122422-37-0

C8H18S*C36H60O30

Conditions
ConditionsYield
for 24h;97.2%
tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

Hexakis(2,6-di-O-tert-butyldimethylsilyl)-α-cyclodextrin
90289-32-0

Hexakis(2,6-di-O-tert-butyldimethylsilyl)-α-cyclodextrin

Conditions
ConditionsYield
In pyridine; N,N-dimethyl-formamide at 100℃; for 18h;97%
With pyridine; dmap In N,N-dimethyl-formamide at 100℃; for 18h;86%
With pyridine; dmap In N,N-dimethyl-formamide at 100℃; for 18h; Inert atmosphere;75%
poly(ethylene glycol)-carboxylic acid, carboxyl content 6.88E-5 mol/g, Mw = 33300, PDI = 1.1

poly(ethylene glycol)-carboxylic acid, carboxyl content 6.88E-5 mol/g, Mw = 33300, PDI = 1.1

1-Adamantanamine
768-94-5

1-Adamantanamine

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

poly(ethylene glycol) 3500, bis[N-(1-adamantyl)aminocarbonyl]-terminated, inclusion complex with α-cyclodextrin, prepared with 1-adamantylamine and 2,4,6-trimethylpyridine

poly(ethylene glycol) 3500, bis[N-(1-adamantyl)aminocarbonyl]-terminated, inclusion complex with α-cyclodextrin, prepared with 1-adamantylamine and 2,4,6-trimethylpyridine

Conditions
ConditionsYield
With 2,4,6-trimethyl-pyridine; (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate In N,N-dimethyl-formamide at 4℃;97%
alpha cyclodextrin
10016-20-3

alpha cyclodextrin

O-acetylsalicyloyl chloride
5538-51-2

O-acetylsalicyloyl chloride

6-[O-(2-acetoxybenzoyl)]-α-cyclodextrin
1332459-75-2

6-[O-(2-acetoxybenzoyl)]-α-cyclodextrin

Conditions
ConditionsYield
With pyridine In N,N-dimethyl-formamide; benzene at 0 - 20℃; regioselective reaction;97%
alpha cyclodextrin
10016-20-3

alpha cyclodextrin

hexakis-(6-bromo-6-deoxy)-α-cyclodextrin
53784-82-0

hexakis-(6-bromo-6-deoxy)-α-cyclodextrin

Conditions
ConditionsYield
With tetrabutylammomium bromide; (chloro-phenylthio-methylene)dimethylammonium chloride In N,N-dimethyl-formamide at 20℃; regioselective reaction;96%
With tetraethylammonium bromide; 4-pyrrolidin-1-ylpyridine; ethanaminium,N-(difluoro-λ4-sulfanylidene)-N-ethyl-,tetrafluoroborate In N,N-dimethyl-formamide at 20℃; regioselective reaction;95%
With bromine; triphenylphosphine In N,N-dimethyl-formamide at 75 - 80℃; for 18h;86%
poly(ethylene glycol)-carboxylic acid, carboxyl content 6.88E-5 mol/g, Mw = 33300, PDI = 1.1

poly(ethylene glycol)-carboxylic acid, carboxyl content 6.88E-5 mol/g, Mw = 33300, PDI = 1.1

amantadine hydrochloride
665-66-7

amantadine hydrochloride

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

poly(ethylene glycol) 3500, bis[N-(1-adamantyl)aminocarbonyl]-terminated, inclusion complex with α-cyclodextrin, prepared with 1-adamantylamine and 4-(dimethylamino)pyridine

poly(ethylene glycol) 3500, bis[N-(1-adamantyl)aminocarbonyl]-terminated, inclusion complex with α-cyclodextrin, prepared with 1-adamantylamine and 4-(dimethylamino)pyridine

Conditions
ConditionsYield
With dmap; (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate In N,N-dimethyl-formamide at 4℃;96%
poly(ethylene glycol)-carboxylic acid, carboxyl content 6.88E-5 mol/g, Mw = 33300, PDI = 1.1

poly(ethylene glycol)-carboxylic acid, carboxyl content 6.88E-5 mol/g, Mw = 33300, PDI = 1.1

amantadine hydrochloride
665-66-7

amantadine hydrochloride

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

poly(ethylene glycol) 3500, bis[N-(1-adamantyl)aminocarbonyl]-terminated, inclusion complex with α-cyclodextrin, prepared with 1-adamantylamine and proton sponge

poly(ethylene glycol) 3500, bis[N-(1-adamantyl)aminocarbonyl]-terminated, inclusion complex with α-cyclodextrin, prepared with 1-adamantylamine and proton sponge

Conditions
ConditionsYield
With N,N,N',N'-tetramethyl-1,8-diaminonaphthalene; (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate In N,N-dimethyl-formamide at 4℃;95%
1,1,1,3,3,3-hexamethyl-disilazane
999-97-3

1,1,1,3,3,3-hexamethyl-disilazane

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

hexakis(2,6-di-O-trimethylsilyl)cyclomaltohexaose

hexakis(2,6-di-O-trimethylsilyl)cyclomaltohexaose

Conditions
ConditionsYield
With trimethylsilyl trifluoromethanesulfonate In dichloromethane at 20℃; for 0.166667h; Inert atmosphere; regioselective reaction;95%
1,3-bisiodobicyclo[1.1.1]pentane
105542-98-1

1,3-bisiodobicyclo[1.1.1]pentane

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

2C36H60O30*C5H6I2

2C36H60O30*C5H6I2

Conditions
ConditionsYield
In water at 20℃; for 3h;95%
1,3 dibromobicyclo[1.1.1]pentane
82783-71-9

1,3 dibromobicyclo[1.1.1]pentane

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

2C36H60O30*C5H6Br2

2C36H60O30*C5H6Br2

Conditions
ConditionsYield
In water at 20℃; for 3h;95%
(1-allyloxy-3-propoxybenzene)
122710-25-2

(1-allyloxy-3-propoxybenzene)

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

A

2-allyl-5-propoxy phenol
122710-44-5

2-allyl-5-propoxy phenol

B

2-allyl-3-propoxy phenol
122710-43-4

2-allyl-3-propoxy phenol

Conditions
ConditionsYield
In solid Irradiation;A 94%
B 5 % Chromat.
1-adamantyl azide
34197-88-1

1-adamantyl azide

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

C10H15N3*2.17C36H60O30

C10H15N3*2.17C36H60O30

Conditions
ConditionsYield
In diethyl ether for 8h; Inert atmosphere; Sonication; Darkness;93%
N-Trimethylsilylacetamide
13435-12-6

N-Trimethylsilylacetamide

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

hexakis(2,6-di-O-trimethylsilyl)cyclomaltohexaose

hexakis(2,6-di-O-trimethylsilyl)cyclomaltohexaose

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 50℃; for 48h;92%
benzoyl chloride
98-88-4

benzoyl chloride

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

α-cyclodextrin 6-O-monobenzoate

α-cyclodextrin 6-O-monobenzoate

Conditions
ConditionsYield
With pyridine In N,N-dimethyl-formamide at 0 - 20℃; regioselective reaction;92%
With pyridine at -7 - 20℃; for 5.7h; Acylation;14%
2-formylbenzene boronic acid
40138-16-7

2-formylbenzene boronic acid

O,O'-diaminododecanediol

O,O'-diaminododecanediol

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

C98H152B2N2O64(2-)*2H(1+)

C98H152B2N2O64(2-)*2H(1+)

Conditions
ConditionsYield
Stage #1: O,O'-diaminododecanediol; alpha cyclodextrin In water at 20℃; for 0.25h;
Stage #2: 2-formylbenzene boronic acid In water at 20℃; for 1h;
92%
polyethylenimine, linear, ; Mw = 3200

polyethylenimine, linear, ; Mw = 3200

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

polypseudorotaxane based on linear polyethylenimine (Mw = 3200) with α-cyclodextrin (threading ratio (repeating unit of polyethylenimine/cyclodextrin) = 2.1); monomer(s): 2-methyl-2-oxazoline, α-cyclodextrin

polypseudorotaxane based on linear polyethylenimine (Mw = 3200) with α-cyclodextrin (threading ratio (repeating unit of polyethylenimine/cyclodextrin) = 2.1); monomer(s): 2-methyl-2-oxazoline, α-cyclodextrin

Conditions
ConditionsYield
In phosphate buffer at 60℃; pH=11.0;91.2%
alpha cyclodextrin
10016-20-3

alpha cyclodextrin

hexakis(6-chloro-6-deoxy)-α-cyclodextrin
173094-59-2

hexakis(6-chloro-6-deoxy)-α-cyclodextrin

Conditions
ConditionsYield
With tetraethylammonium chloride; 4-pyrrolidin-1-ylpyridine; ethanaminium,N-(difluoro-λ4-sulfanylidene)-N-ethyl-,tetrafluoroborate In N,N-dimethyl-formamide at 20℃; regioselective reaction;91%
With methanesulfonyl chloride In N,N-dimethyl-formamide at 65℃; for 48h;90%
With methanesulfonyl chloride In N,N-dimethyl-formamide at 65℃; for 48h;80%
1-iodo-3-methylbicyclo<1.1.1>pentane
136399-10-5

1-iodo-3-methylbicyclo<1.1.1>pentane

alpha cyclodextrin
10016-20-3

alpha cyclodextrin

2C36H60O30*C6H9I

2C36H60O30*C6H9I

Conditions
ConditionsYield
In water at 20℃; for 3h;91%
alpha cyclodextrin
10016-20-3

alpha cyclodextrin

neopentyl glycol di(3-azido-2-hydroxylpropan-1-ol)
17557-23-2

neopentyl glycol di(3-azido-2-hydroxylpropan-1-ol)

2C36H60O30*C11H20O4

2C36H60O30*C11H20O4

Conditions
ConditionsYield
In water at 20℃; for 10h; inclusion;90%

10016-20-3Upstream product

10016-20-3Relevant articles and documents

NMR Detection of Simultaneous Formation of [2]- and [3]Pseudorotaxanes in Aqueous Solution between α-Cyclodextrin and Linear Aliphatic α,ω-Amino acids, an α,ω-Diamine and an α,ω-Diacid of Similar Length, and Comparison with the Solid-State Structures

Eliadou, Kyriaki,Yannakopoulou, Konstantina,Rontoyianni, Aliki,Mavridis, Irene M.

, p. 6217 - 6226 (1999)

The interactions of 11-aminoundecanoic acid (1), 12-aminododecanoic acid (2), 1,12-diaminododecane (3), and 1,13-tridecanoic diacid (4) with α-cyclodextrin (αCD) were studied in aqueous solution by NMR spectroscopy. The association modes were established with titration and continuous variation plots, variable temperature NMR spectra, and dipolar interactions as recorded in 2D ROESY spectra. The studies were carried out at pH 7.3 and 13.6. These long, linear bifunctional molecules were found to form simultaneously [2]- and [3]pseudorotaxanes with αCD in the aqueous solution. At the higher pH the 1:1 adducts were present at concentrations higher than at the neutral pH. The longer guests formed complexes enriched in the 2:1 constituent at both pH values. There were clear indications that the [2]pseudorotaxanes are present in two isomeric forms. The presence of isomers also in the [3]pseudorotaxanes was not ruled out. Various exchange rate regimes were observed; clearly in neutral solutions the formation of the 1:1 complexes was fast in the NMR time scale, whereas the threading of a second αCD ring was a slower process. In the solid state, the adduct of αCD/2 had the structure of a [3]pseudorotaxane, in accordance with previously solved crystal structures of αCD/3 and βCD/4. The species in solution, in contrast with those present in the solid state, are therefore of varying nature, and thus the frequently and conveniently assumed 1:1 stoichiometry in similar systems is an oversimplification of the real situation.

Solid state polycondensation within cyclodextrin channels leading to watersoluble polyamide rotaxanes

Wenz, Gerhard,Steinbrunn, Marc Boris,Landfester, Katharina

, p. 15575 - 15592 (1997)

α,ω-Aminocarboxylic acids form microcrystalline inclusion compounds with α-cyclodextrin. In these inclusion compounds cyclodextrins build up channel structures, in which the α,ω-aminocarboxylic acids can be polycondensed at 200-240°C. As the resulting pol

Thermodynamic and nuclear magnetic resonance study of the reactions of α- and β-cyclodextrin with acids, aliphatic amines, and cyclic alcohols

Rekharsky, Mikhail V.,Mayhew, Martin P.,Goldberg, Robert N.,Ross, Philip D.,Yamashoji, Yuko,Inoue, Yoshihisa

, p. 87 - 100 (1997)

Titration calorimetry was used to determine equilibrium constants and standard molar enthalpy, Gibbs energy, and entropy changes for the reactions of a series of acids, amines, and cyclic alcohols with α- and β-cyclodextrin. The results have been examined in terms of structural features in the ligands such as the number of alkyl groups, the charge number, the presence of a double bond, branching, and the presence of methyl and methoxy groups. The values of thermodynamic quantities, in particular the standard molar Gibbs energy, correlate well with the structural features in the ligands. These structural correlations can be used for the estimation of thermodynamic quantities for related reactions. Enthalpy-entropy compensation is evident when the individual classes of substances studied herein are considered, but does not hold when these various classes of ligands are considered collectively. The NMR results indicate that the mode of accommodation of the acids and amines in the α-cyclodextrin cavity is very similar, but that the 1-methyl groups in 1-methylhexylamine and in 1-methylheptylamine and the N-methyl group in N-methylhexylamine lie outside the α-cyclodextrin cavity. This latter finding is consistent with the calorimetric results. Many of the thermodynamic and NMR results can be qualitatively understood in terms of van der Waals forces and hydrophobic effects.

Kinetics of the self-assembly of α-cyclodextrin [2]pseudorotaxanes with 1,12-bis(4-(α-alkyl-α-methylmethanol)pyridinium)dodecane dications in aqueous solution

Smith, A. Catherine,Macartney, Donal H.

, p. 9243 - 9251 (1998)

The kinetics and thermodynamics of the self-assembly of a series of [2]pseudorotaxanes comprised of α-cyclodextrin (α-CD) and racemic 1,12- bis(4-(α-alkyl-α-methylmethanol)pyridinium)dodecane dications (L(CH2)12L2+) in aqueous solutions have been investigated using 1H NMR spectroscopy. The mechanism of assembly involves inclusion of the α-methyl- α-alkylmethanol substituent groups (-C(CH3)(OH)R, where R = Me, Et, Pr, Bu, allyl, and 4-butenyl) by α-CD, followed by a rate-determining passage of the cyclodextrin over the pyridinium group onto the dodecamethylene chain. Dicationic threads containing end groups with R = Ph or i-Pr or where L = 4- (α,α-diethylmethanol)-pyridinium did not form α-cyclodextrin pseudorotaxanes, even after prolonged heating. The trends in the rate and activation parameters may be related to the size, shape, and hydrophobicity of the alkyl substituents and are compared with several other systems from the literature. An increase in the length and hydrophobicity of the alkyl group increases the strength of end group inclusion and decreases the rate of threading. In addition, the presence of unsaturation in the alkyl substituent (allyl vs propyl and 4-butenyl vs butyl) results in an increase in the threading rate constant.

Volume Change on Complex Formation Between Anions and Cyclodextrins in Aqueous Solution

Hoeiland, H.,Hald, L.H.,Kvammen, O.J.

, p. 775 - 784 (1981)

Partial molal volume changes during complex formation between SCN(1-), I(1-), and ClO4(1-) and α- and β-cyclodextrin have been determined by two independent methods of measurements; one based on density measurement and subsequent calculation of apparent molal volumes, the other on differentiating the association constants with respect to pressure.Results from the two methods are in good agreement.Negative volume changes were observed for complex formation between the anions and α-cyclodextrin while zero or slightly positive values were observed for complex formation with β-cyclodextrin.The result is consistent with the idea that the anions do not become dehydrated as they form complexes with cyclodextrins.

Retardation of acetal hydrolysis by cyclodextrins and its use in probing cyclodextrin-guest binding

Tee, Oswald S.,Fedortchenko, Alexei A.,Soo, Patrick Lim

, p. 123 - 128 (1998)

Hydrolysis of benzaldehyde dimethyl acetal 1 in aqueous acid is slowed down greatly by cyclodextrins (SDs): α-CD, β-CD, hp-β-CD (hydroxypropyl-β-cyclodextrin) and γ-CD. The variations of the observed first-order rate constants (Kobs) with [CD] exhibit saturation behaviour consistent with 1:1 binding between 1 and the CDs. In the case of β-CD and hp-β-CD, the binding is relatively strong and the CD-bound acetal is unreactive. In contrast, binding of the acetal by α-CD and γ-CD is much weaker, but only with α-CD does the CD-bound form show significant reactivity. The four CD-mediated reaction, have been evaluated as probe reactions for determining dissociation constants of {CD-'guest'} complexes. In this approach, added guests attenuate the retarding effect of CD-substrate binding and cause an increase in the rate of acetal hydrolysis. The method works well for alipharic alcohols and ketones binding to β-CD and hp-β-CD, but it is less successful with α-CD because of the shallow dependence of kobs on [α-CD] in the probe action. With γ-CD, the approach is not applicable at all, because added guests cause a further reduction in the rate of acetal hydrolysis, not an increase. Various implications of these findings are discussed.

Catalysis of ester aminolysis by cyclodextrins. The reaction of alkylamines with p-nitrophenyl alkanoates

Gadosy,Boyd,Tee

, p. 6879 - 6889 (2000)

The effects of four cyclodextrins (α-CD, β-CD, hydroxypropyl-β-CD, and γ-CD) on the aminolysis of p-nitrophenyl alkanoates (acetate to heptanoate) by primary amines (n-propyl to n-octyl, isobutyl, isopentyl, cyclopentyl, cyclohexyl, benzyl) in aqueous solution have been investigated. Rate constants for amine attack on the free and CD-bound esters (k(N) and k(cN)) have ratios (k(cN)/k(N)) varying from 0.08 (retardation) to 180 (catalysis). For the kinetically equivalent process of free ester reacting with CD-bound amine (k(Nc)), the ratios k(Nc)/k(N) vary from 0.2 to 28. Either way, there is evidence of catalysis in some cases and retardation in others. Changes in reactivity parameters with structure indicate more than one mode of transition state binding to the CDs. Short esters react with short alkylamines by attack of free amine on the ester bound by its aryl group, but for longer amines, free ester reacts with CD-bound amine. Reaction of long esters with long amines, which is catalyzed by β-CD and γ-CD, involves inclusion of the alkylamino group and possibly the ester acyl group. The larger cavity of γ-CD may allow the inclusion of the ester aryl group, as well as the alkylamino group, in the transition state. Reaction between an ester bound to the CD by its acyl group and free amine appears not to be important.

Altered product specificity of a cyclodextrin glycosyltransferase by molecular imprinting with cyclomaltododecaose

Kaulpiboon, Jarunee,Pongsawasdi, Piamsook,Zimmermann, Wolfgang

, p. 480 - 485 (2010)

Cyclodextrin glycosyltransferases (CGTases), members of glycoside hydrolase family 13, catalyze the conversion of amylose to cyclodextrins (CDs), circular α-(1,4)-linked glucopyranose oligosaccharides of different ring sizes. The CD containing 12 α-D-gluc

Induced circular dichroism and UV-VIS absorption spectroscopy of cyclodextrin inclusion complexes: Structural elucidation of supramolecular azi-adamantane

Krois, Daniel,Brinker, Udo H.

, p. 11627 - 11632 (1998)

The first induced circular dichroism (ICD) analyses of diazirineγyciodextrin inclusion complexes are reported. The stoichiometries and association constants of the guestηost complexes with α-, β-, and γ- cyclodextrin were determined. In addition, with the α-cyclodextrin complex, UV-vis spectroscopy of water-ethanol solutions showed remarkable fine structure, probably indicating that the diazirine experiences a nonpolar microenvironment. These analytical methods provide details about the architecture and nature of these supramolecular carbene precursors.

Cyclodextrin Inclusion Complexes of 1-Pyrenebutyrate: The Role of Coinclusion of Amphiphiles

Herkstroeter, William G.,Martic, Peter A.,Evans, Ted R.,Farid, Samir

, p. 3275 - 3280 (1986)

Several inclusion complexes with various stoichiometries are formed from 1-pyrenebutyrate ion (P) and the different cyclodextrins (α-, β-, and γ-CD).With α- and β-CD, the initially formed 1:1 complexes lead to the formation of 1:2 complexes (P*α2 and P*β2).As P can be only partially included in the small cavity of α-CD, the equilibrium constants for the formation of both complexes of α-CD are about an order of magnitude smaller than those of β-CD.For the same reason, P*β2, to which we assign a "barrel" configuration, is also an order of magnitude more effective than P*α2 in protecting singlet-excited P against quenching by triethanolamine.We had shown earlier that with γ-CD the 1:1 complex (P*γ) dimerizes to a 2:2 complex (P2*γ2), to which we also assigned a barrel configuration.The lack of efficient 1:2 complex formation in this case is attributed to the large size of the "barrel" enclosed by two γ-CD molecules.The extra space next to a single P molecule in such a cavity would have to be filled with water.However, the formation of a 1:2 inclusion complex between P and γ-CD can be induced by the coinclusion of a molecule with a hydrophobic moiety such as sodium hexanesulfonate (X).This replaces the water within the cavity and leads to the formation of P*X*γ2.This complex provides the highest degree of protection against quenching of excited P in these inclusion complexes.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 10016-20-3